In a report released today, Nat Schindler from Scotiabank maintained a Hold rating on Trade Desk (TTD – Research Report), with a price target ...
As previously reported, Scotiabank analyst George Farmer initiated coverage of Viking Therapeutics (VKTX) with an Outperform rating and $102 ...
Alimentation Couche-Tard (TSE:ATD – Get Free Report) had its price target reduced by research analysts at Desjardins from C$87.00 to C$84.00 in a research report issued to clients and investors on ...
It was supposed to be a simple end to a blowout game in Toronto against Cleveland, until Tristan Thompson decided to break an ...
Your TFSA isn't just for saving; it's for making money. So, here's how to start pumping it out with just $12,000.
We've got another exciting Eastern Conference matchup on Wednesday's NBA schedule as the Cleveland Cavaliers will visit the ...
It’s Wednesday, February 12, and the Cleveland Cavaliers (43-10) and Toronto Raptors (17-37) are all set to square off from ...
Scotiabank analyst Allan Verkhovski raised the firm’s price target on Monday.com (MNDY) to $400 from $300 and keeps an ...
Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform ...
Scotiabank (TSX:BNS) analyst Nick Altmann increased the price target on Confluent Inc (NASDAQ:CFLT) to $35.00, up from $27.00, while reiterating a Sector Perform rating on the stock. Altmann's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results